113 related articles for article (PubMed ID: 26776446)
1. Routine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154 Patients.
Johnson E; Babb J; Sridhar D
J Vasc Interv Radiol; 2016 Mar; 27(3):339-43; quiz 344. PubMed ID: 26776446
[TBL] [Abstract][Full Text] [Related]
2. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
Covey AM; Toro-Pape FW; Thornton RH; Son C; Erinjeri J; Sofocleous CT; Brody LA; Brown KT; Sepkowitz KA; Getrajdman GI
J Vasc Interv Radiol; 2012 Mar; 23(3):358-62. PubMed ID: 22365295
[TBL] [Abstract][Full Text] [Related]
3. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
Jo JE; Tang EY; Pua BB
Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
[TBL] [Abstract][Full Text] [Related]
4. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution.
Choksi A; Finnegan K; Etezadi V
Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.
Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I
Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229
[TBL] [Abstract][Full Text] [Related]
6. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial.
Karanlik H; Kurul S; Saip P; Unal ES; Sen F; Disci R; Topuz E
Am J Surg; 2011 Jul; 202(1):10-5. PubMed ID: 21601826
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of antibiotic prophylaxis in patients undergoing elective laparoscopic cholecystectomy: A systematic review and meta-analysis.
Liang B; Dai M; Zou Z
J Gastroenterol Hepatol; 2016 May; 31(5):921-8. PubMed ID: 26637110
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic prophylaxis in the placement of totally implanted central venous access ports.
Scaife CL; Gross ME; Mone MC; Hansen HJ; Litz CL; Nelson ET; Anderson CJ; Wagner G; Gawlick U; Nelson EW
Am J Surg; 2010 Dec; 200(6):719-22; disussion 722-3. PubMed ID: 21146010
[TBL] [Abstract][Full Text] [Related]
9. Reduction or discontinuation of antibiotic prophylaxis in vascular access surgery, tendon sheath incision and PD catheter placement.
Nagai K; Tsuchida K; Sasada M; Yokota N; Nishitani M; Kanayama HO; Minakuchi J
J Vasc Access; 2015 Nov; 16 Suppl 10():S66-9. PubMed ID: 26349895
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal antibiotic administration for prevention of postoperative peritoneal catheter-related infections.
Kunin M; Dinour D; Rosin D
Clin Exp Nephrol; 2018 Apr; 22(2):448-452. PubMed ID: 28913721
[TBL] [Abstract][Full Text] [Related]
11. Is there any effect of first-day usage of a totally implantable venous access device on complications?
Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Antibiotics for Reducing Central Line-associated Blood Stream Infection in Children with Totally Implantable Venous Access Devices.
Akbar SA; Qudsia ZF; Ashraf MN; Tarar MA; Qazi AQ
J Coll Physicians Surg Pak; 2020 Mar; 30(3):304-308. PubMed ID: 32169141
[TBL] [Abstract][Full Text] [Related]
13. Infection of totally implantable venous access devices: A review of the literature.
Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
[TBL] [Abstract][Full Text] [Related]
14. Risk of Resistant Organisms and Clostridium difficile with Prolonged Systemic Antibiotic Prophylaxis for Central Nervous System Devices.
Chauv S; Fontaine GV; Hoang QP; McKinney CB; Baldwin M; Buckel WR; Collingridge DS; Majercik S; Wohlt PD
Neurocrit Care; 2016 Aug; 25(1):128-32. PubMed ID: 26920907
[TBL] [Abstract][Full Text] [Related]
15. Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies.
Wu S; Huang J; Jiang Z; Huang Z; Ouyang H; Deng L; Lin W; Guo J; Zeng W
BMC Cancer; 2016 Sep; 16(1):747. PubMed ID: 27658952
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Poeran J; Mazumdar M; Rasul R; Meyer J; Sacks HS; Koll BS; Wallach FR; Moskowitz A; Gelijns AC
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):589-97.e2. PubMed ID: 26545971
[TBL] [Abstract][Full Text] [Related]
17. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC
Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958
[TBL] [Abstract][Full Text] [Related]
18. Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
El-Balat A; Schmeil I; Karn T; Holtrich U; Mavrova-Risteska L; Rody A; Youssef A; Hanker LC
In Vivo; 2018; 32(5):1275-1281. PubMed ID: 30150457
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors of the Totally Implantable Venous Access Device-Related Infection in Patients With Brain Tumors Undergoing Chemotherapy After Surgery.
Li H; Shan J
Surg Infect (Larchmt); 2024 Mar; 25(2):133-139. PubMed ID: 38265425
[No Abstract] [Full Text] [Related]
20. Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study.
Di Carlo I; Toro A; Pulvirenti E; Palermo F; Scibilia G; Cordio S
Surg Oncol; 2011 Mar; 20(1):20-5. PubMed ID: 19819688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
